SDF-1 (Dutch Wikipedia)

Analysis of information sources in references of the Wikipedia article "SDF-1" in Dutch language version.

refsWebsite

Global rank Dutch rank

19nih.gov

4^th place

12^th place

18doi.org

2^nd place

8^th place

4archive.org

6^th place

25^th place

1biogps.org

low place

1egms.de

low place

1uni-konstanz.de

low place

1sciencedirect.com

149^th place

200^th place

archive.org

Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS (August 2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362 (9385): 697–703. PMID 12957092. DOI: 10.1016/S0140-6736(03)14232-8.
Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F (2005). The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. The Journal of Biological Chemistry 280 (42): 35760–6. PMID 16107333. DOI: 10.1074/jbc.M508234200.
Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ (2006). A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. The Journal of Experimental Medicine 203 (9): 2201–13. PMID 16940167. PMC 2118398. DOI: 10.1084/jem.20052144.
Li M, Hale JS, Rich JN, Ransohoff RM, Lathia JD (October 2012). Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair. Trends in Neurosciences 35 (10): 619–28. PMID 22784557. PMC 3461091. DOI: 10.1016/j.tins.2012.06.003.

biogps.org

BioGPS - your Gene Portal System. biogps.org. Geraadpleegd op 11 oktober 2016.

doi.org

(August 2016). CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer. Oncotarget 7 (38): 62006–62018. PMID 27542220. PMC 5308707. DOI: 10.18632/oncotarget.11330.
Sorrentino C, Miele L, Porta A, Pinto A, Morello S (August 2016). Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression. Oncotarget 7 (39): 64274–64288. PMID 27590504. PMC 5325441. DOI: 10.18632/oncotarget.11729.
(June 2015). Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet 385 (9984): 2264–71. PMID 25748612. PMC 4608367. DOI: 10.1016/S0140-6736(14)61730-X.
Schrader AJ, Lechner O, Templin M, Dittmar KE, Machtens S, Mengel M, Probst-Kepper M, Franzke A, Wollensak T, Gatzlaff P, Atzpodien J, Buer J, Lauber J (April 2002). CXCR4/CXCL12 expression and signalling in kidney cancer. British Journal of Cancer 86 (8): 1250–6. PMID 11953881. PMC 2375348. DOI: 10.1038/sj.bjc.6600221.
Custo S, Baron B, Felice A, Seria E (5 July 2022). A comparative profile of total protein and six angiogenically-active growth factors in three platelet products. GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW 11 (Doc06): Doc06. PMID 35909816. PMC 9284722. DOI: 0.3205/iprs000167.
Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA (September 1996). A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). The Journal of Experimental Medicine 184 (3): 1101–9. PMID 9064327. PMC 2192798. DOI: 10.1084/jem.184.3.1101.
Ara T, Nakamura Y, Egawa T, Sugiyama T, Abe K, Kishimoto T, Matsui Y, Nagasawa T (April 2003). Impaired colonization of the gonads by primordial germ cells in mice lacking a chemokine, stromal cell-derived factor-1 (SDF-1). Proceedings of the National Academy of Sciences of the United States of America 100 (9): 5319–23. PMID 12684531. PMC 154343. DOI: 10.1073/pnas.0730719100.
Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS (August 2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362 (9385): 697–703. PMID 12957092. DOI: 10.1016/S0140-6736(03)14232-8.
Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA (August 1998). Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 95 (16): 9448–53. PMID 9689100. PMC 21358. DOI: 10.1073/pnas.95.16.9448.
Takano T, Li YJ, Kukita A, Yamaza T, Ayukawa Y, Moriyama K, Uehara N, Nomiyama H, Koyano K, Kukita T (2014). Mesenchymal stem cells markedly suppress inflammatory bone destruction in rats with adjuvant-induced arthritis. Laboratory Investigation 94 (3): 286–96. PMID 24395111. DOI: 10.1038/labinvest.2013.152.
Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F (2005). The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. The Journal of Biological Chemistry 280 (42): 35760–6. PMID 16107333. DOI: 10.1074/jbc.M508234200.
Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ (2006). A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. The Journal of Experimental Medicine 203 (9): 2201–13. PMID 16940167. PMC 2118398. DOI: 10.1084/jem.20052144.
Cruz-Orengo L, Holman DW, Dorsey D, Zhou L, Zhang P, Wright M, McCandless EE, Patel JR, Luker GD, Littman DR, Russell JH, Klein RS (2011). CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. The Journal of Experimental Medicine 208 (2): 327–39. PMID 21300915. PMC 3039853. DOI: 10.1084/jem.20102010.
Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B (1996). The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382 (6594): 833–5. PMID 8752281. DOI: 10.1038/382833a0.
Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G (July 2001). Chemokines and their receptors in the central nervous system. Frontiers in Neuroendocrinology 22 (3): 147–84. PMID 11456467. DOI: 10.1006/frne.2001.0214.
Li M, Hale JS, Rich JN, Ransohoff RM, Lathia JD (October 2012). Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair. Trends in Neurosciences 35 (10): 619–28. PMID 22784557. PMC 3461091. DOI: 10.1016/j.tins.2012.06.003.
Guyon A (March 2014). CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems. Frontiers in Cellular Neuroscience 8: 65. PMID 24639628. PMC 3944789. DOI: 10.3389/fncel.2014.00065.
Goltz D, Holmes EE, Gevensleben H, Sailer V, Dietrich J, Jung M, Röhler M, Meller S, Ellinger J, Kristiansen G, Dietrich D (July 2016). CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients. Oncotarget 7 (33): 53309–53320. PMID 27462860. PMC 5288188. DOI: 10.18632/oncotarget.10786.

egms.de

Custo S, Baron B, Felice A, Seria E (5 July 2022). A comparative profile of total protein and six angiogenically-active growth factors in three platelet products. GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW 11 (Doc06): Doc06. PMID 35909816. PMC 9284722. DOI: 0.3205/iprs000167.

nih.gov

ncbi.nlm.nih.gov

Entrez Gene: CXCL12 chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1).
(August 2016). CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer. Oncotarget 7 (38): 62006–62018. PMID 27542220. PMC 5308707. DOI: 10.18632/oncotarget.11330.
Sorrentino C, Miele L, Porta A, Pinto A, Morello S (August 2016). Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression. Oncotarget 7 (39): 64274–64288. PMID 27590504. PMC 5325441. DOI: 10.18632/oncotarget.11729.
(June 2015). Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet 385 (9984): 2264–71. PMID 25748612. PMC 4608367. DOI: 10.1016/S0140-6736(14)61730-X.
Schrader AJ, Lechner O, Templin M, Dittmar KE, Machtens S, Mengel M, Probst-Kepper M, Franzke A, Wollensak T, Gatzlaff P, Atzpodien J, Buer J, Lauber J (April 2002). CXCR4/CXCL12 expression and signalling in kidney cancer. British Journal of Cancer 86 (8): 1250–6. PMID 11953881. PMC 2375348. DOI: 10.1038/sj.bjc.6600221.
Custo S, Baron B, Felice A, Seria E (5 July 2022). A comparative profile of total protein and six angiogenically-active growth factors in three platelet products. GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW 11 (Doc06): Doc06. PMID 35909816. PMC 9284722. DOI: 0.3205/iprs000167.
Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA (September 1996). A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). The Journal of Experimental Medicine 184 (3): 1101–9. PMID 9064327. PMC 2192798. DOI: 10.1084/jem.184.3.1101.
Ara T, Nakamura Y, Egawa T, Sugiyama T, Abe K, Kishimoto T, Matsui Y, Nagasawa T (April 2003). Impaired colonization of the gonads by primordial germ cells in mice lacking a chemokine, stromal cell-derived factor-1 (SDF-1). Proceedings of the National Academy of Sciences of the United States of America 100 (9): 5319–23. PMID 12684531. PMC 154343. DOI: 10.1073/pnas.0730719100.
Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS (August 2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362 (9385): 697–703. PMID 12957092. DOI: 10.1016/S0140-6736(03)14232-8.
Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA (August 1998). Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 95 (16): 9448–53. PMID 9689100. PMC 21358. DOI: 10.1073/pnas.95.16.9448.
Takano T, Li YJ, Kukita A, Yamaza T, Ayukawa Y, Moriyama K, Uehara N, Nomiyama H, Koyano K, Kukita T (2014). Mesenchymal stem cells markedly suppress inflammatory bone destruction in rats with adjuvant-induced arthritis. Laboratory Investigation 94 (3): 286–96. PMID 24395111. DOI: 10.1038/labinvest.2013.152.
Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F (2005). The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. The Journal of Biological Chemistry 280 (42): 35760–6. PMID 16107333. DOI: 10.1074/jbc.M508234200.
Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ (2006). A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. The Journal of Experimental Medicine 203 (9): 2201–13. PMID 16940167. PMC 2118398. DOI: 10.1084/jem.20052144.
Cruz-Orengo L, Holman DW, Dorsey D, Zhou L, Zhang P, Wright M, McCandless EE, Patel JR, Luker GD, Littman DR, Russell JH, Klein RS (2011). CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. The Journal of Experimental Medicine 208 (2): 327–39. PMID 21300915. PMC 3039853. DOI: 10.1084/jem.20102010.
Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B (1996). The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382 (6594): 833–5. PMID 8752281. DOI: 10.1038/382833a0.
Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G (July 2001). Chemokines and their receptors in the central nervous system. Frontiers in Neuroendocrinology 22 (3): 147–84. PMID 11456467. DOI: 10.1006/frne.2001.0214.
Li M, Hale JS, Rich JN, Ransohoff RM, Lathia JD (October 2012). Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair. Trends in Neurosciences 35 (10): 619–28. PMID 22784557. PMC 3461091. DOI: 10.1016/j.tins.2012.06.003.
Guyon A (March 2014). CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems. Frontiers in Cellular Neuroscience 8: 65. PMID 24639628. PMC 3944789. DOI: 10.3389/fncel.2014.00065.
Goltz D, Holmes EE, Gevensleben H, Sailer V, Dietrich J, Jung M, Röhler M, Meller S, Ellinger J, Kristiansen G, Dietrich D (July 2016). CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients. Oncotarget 7 (33): 53309–53320. PMID 27462860. PMC 5288188. DOI: 10.18632/oncotarget.10786.

sciencedirect.com

Sciencedirect. Stromal Cell Derived Factor 1

uni-konstanz.de

kops.uni-konstanz.de

Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B (1996). The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382 (6594): 833–5. PMID 8752281. DOI: 10.1038/382833a0.